Page 2 - Hiv Aids

Goal to end AIDS by 2030 'badly off track', says UNGA President Korosi

There is a science-based path to ending AIDS, but regrettably, it is not available to all, he said

SC issues notice to Centre on plea alleging shortage of anti-HIV drugs

The Supreme Court has sought response from the Centre and others on a plea alleging shortage of antiretroviral drugs for treating HIV patients in the country. A bench of Justices D Y Chandrachud and Hima Kohli issued notice to the Ministry of Health, National AIDS Control Organisation and others on a plea filed by an NGO. "The petitioners have submitted that there are shortages in the procurement of ART drugs in the country and the tender for 2021-22, which was due in August 2021, was issued in December 2021 and eventually failed. Issue notice, returnable in two weeks," the bench said. Antiretroviral therapy (ART) is treatment of people infected with human immunodeficiency virus (HIV) using anti-HIV drugs. The top court was hearing a plea filed by NGO Indian Network for People living with HIV/AIDS alleging shortage of antiretroviral drugs in the country. The plea contended that non-availability of drugs at the Anti Retro Viral Therapy Centres of the National AIDS Control Organisat

South Africa to refocus on HIV, TB after neglect during Covid pandemic

South Africa said it will focus its attention now on catching up on the backlog in identifying HIV and TB cases that were out on the backburner during the COVID-19 pandemic.

Luc Montagnier, who identified virus behind AIDS, dies at 89

French researcher Luc Montagnier, who won a Nobel Prize in 2008 for discovering the HIV virus and more recently spread false claims about the coronavirus, has died at age 89, according to officials

More than 1.2 mn people died from drug-resistant infections in 2019: Study

Drug-resistant bacteria and other microbes are rising due to the misuse and overuse of antibiotics, say health officials.

Best of BS Opinion: Reform in agriculture, public investment push and more

Here is the best of Business Standard's opinion pieces for Friday

Joe Biden unveils new national HIV/AIDS strategy on World AIDS Day

US President Joe Biden has initiated a new HIV/AIDS strategy aimed at ending the epidemic by 2030, local news reported on Wednesday (local time).

Kerala determined to prevent new HIV infections by 2025: CM Vijayan

Kerala is determined to prevent new HIV infections in the state by 2025 and due to the significant strides it has made in the health sector it can achieve this goal much earlier, Vijayan said

People living with HIV/AIDS may be less susceptible to Covid: AIIMS study

The average seropositivity in Delhi was 25.7 per cent at the time when the samples from persons with HIV/AIDS were collected between September and November 2020.

Zydus Cadila receives tentative nod from USFDA to market two HIV drugs

The drug will be manufactured at the group's formulation manufacturing facility at the SEZ Ahmedabad

Covid-19 isn't relatively harmless for younger adults as thought earlier

New research shows that July may have been the deadliest month for young adults in modern American history

Decades of battle against AIDS holds crucial lessons in fight against Covid

These diseases take incredible expertise, collaboration and dedication from all levels of society to track, understand, treat and prevent

World Coronavirus Dispatch: Zambia's default sparks fears of debt tsunami

Pandemic puts AIDS-related gains at risk, Museum of London asks citizens to share Covid dreams, virus revives debate on value of high-stake exams, and other pandemic-related news across the globe

Not only Covid, research underway to find vaccine for three other diseases

Deaths from these three diseases could almost double over the next year as a result of disruptions to health care in the face of Covid-19

Zydus Cadila gets USFDA nod for generic antiviral drug, Atazanavir capsules

Atazanavir, an antiretroviral drug, is used to treat Human Immunodeficiency Virus (HIV-1) infection incombination with other antiretroviral drugs

Vaccinating policy

IP regimes should not outweigh public health interests

Vaccinating policy

IP regimes should not outweigh public health interests

We aren't dying in droves as some predicted, but can you handle this truth?

India isn't going through a picnic. But our drains aren't filled with bodies, hospitals haven't run out of beds, crematoriums and graveyards not out of wood or space

No cure for HIV yet, but early diagnosis may help lead longer lives

An HIV patient who has received timely treatment can live a normal and long life without progressing to late stage HIV

GSK's HIV venture fails to get USFDA approval for once-a-month injection

ViiV Healthcare received a complete response letter from the Food and Drug Administration, which cited "chemistry manufacturing and controls," according to a statement from the HIV unit